These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25929975)

  • 1. The CYP17 MspA1 Polymorphism and the Gender Dysphoria.
    Fernández R; Cortés-Cortés J; Esteva I; Gómez-Gil E; Almaraz MC; Lema E; Rumbo T; Haro-Mora JJ; Roda E; Guillamón A; Pásaro E
    J Sex Med; 2015 Jun; 12(6):1329-33. PubMed ID: 25929975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polymorphism of the CYP17 gene related to sex steroid metabolism is associated with female-to-male but not male-to-female transsexualism.
    Bentz EK; Hefler LA; Kaufmann U; Huber JC; Kolbus A; Tempfer CB
    Fertil Steril; 2008 Jul; 90(1):56-9. PubMed ID: 17765230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
    Ye Z; Parry JM
    Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
    Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
    Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cytochrome-17 (MspA1) Gene Polymorphism with Risk of Gall Bladder Stones and Cancer in North India.
    Dwivedi S; Agrawal S; Singh S; Madeshiya AK; Singh D; Mahdi AA; Chandra A
    Asian Pac J Cancer Prev; 2015; 16(13):5557-63. PubMed ID: 26225710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.
    Song G; Gu L; Tian F; Bao Q; Tang Z; Wang S
    Medicina (Kaunas); 2013; 49(2):51-5. PubMed ID: 23888338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
    Allen NE; Forrest MS; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
    Hou L; Xu J; Gao YT; Rashid A; Zheng SL; Sakoda LC; Shen MC; Wang BS; Deng J; Han TQ; Zhang BH; Meyers DA; Fraumeni JF; Hsing AW
    Int J Cancer; 2006 Jun; 118(11):2847-53. PubMed ID: 16381022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP17 gene polymorphism and its association in north Indian prostate cancer patients.
    Sobti RC; Gupta L; Thakur H; Seth A; Singh SK; Kaur P
    Anticancer Res; 2009 May; 29(5):1659-63. PubMed ID: 19443382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of Gender Dysphoria: androgen and estrogen receptor interaction.
    Fernández R; Guillamon A; Cortés-Cortés J; Gómez-Gil E; Jácome A; Esteva I; Almaraz M; Mora M; Aranda G; Pásaro E
    Psychoneuroendocrinology; 2018 Dec; 98():161-167. PubMed ID: 30165284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between polymorphism of CYP17 gene and serum hormone concentrations in aged men].
    Wang JQ; Gu X; Chen JC; Sun XQ; Mu HT; Wei ZH; Li M; Xin DQ; Na YQ
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):442-4. PubMed ID: 15999490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations.
    Asghar T; Yoshida S; Nakago S; Morizane M; Ohara N; Motoyama S; Kennedy S; Barlow D; Maruo T
    Gynecol Endocrinol; 2005 Feb; 20(2):59-63. PubMed ID: 15823822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common polymorphism of the SRD5A2 gene and transsexualism.
    Bentz EK; Schneeberger C; Hefler LA; van Trotsenburg M; Kaufmann U; Huber JC; Tempfer CB
    Reprod Sci; 2007 Oct; 14(7):705-9. PubMed ID: 18000232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.
    Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R
    Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.
    Mao C; Wang XW; He BF; Qiu LX; Liao RY; Luo RC; Chen Q
    Breast Cancer Res Treat; 2010 Jul; 122(1):259-65. PubMed ID: 20033766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.
    Kuligina ES; Togo AV; Suspitsin EN; Grigoriev MY; Pozharisskiy KM; Chagunava OL; Berstein LM; Theillet C; Hanson KP; Imyanitov EN
    Cancer Lett; 2000 Aug; 156(1):45-50. PubMed ID: 10840158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of ERβ, AR, and CYP19A1 genes and MtF transsexualism.
    Fernández R; Esteva I; Gómez-Gil E; Rumbo T; Almaraz MC; Roda E; Haro-Mora JJ; Guillamón A; Pásaro E
    J Sex Med; 2014 Dec; 11(12):2986-94. PubMed ID: 25124466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.